Tecan Group AG (0QLN.L)

CHF 162.88

(3.52%)

Operating Expenses Summary of Tecan Group AG

  • Tecan Group AG's latest annual operating expenses in 2023 was 254.49 Million CHF , down -1.88% from previous year.
  • Tecan Group AG's latest quarterly operating expenses in 2024 Q2 was 134.87 Million CHF , down 0.0% from previous quarter.
  • Tecan Group AG reported a annual operating expenses of 259.36 Million CHF in annual operating expenses 2022, up 5.05% from previous year.
  • Tecan Group AG reported a annual operating expenses of 246.89 Million CHF in annual operating expenses 2021, up 13.85% from previous year.
  • Tecan Group AG reported a quarterly operating expenses of 143.1 Million CHF for 2023 Q2, down 0.0% from previous quarter.
  • Tecan Group AG reported a quarterly operating expenses of 254.49 Million CHF for 2023 FY, down -1.88% from previous quarter.

Annual Operating Expenses Chart of Tecan Group AG (2023 - 2002)

Created with Highcharts 11.1.0YearsOperating Expenses20022004200620082010201220142016201820202022100000000 CHF150000000 CHF200000000 CHF250000000 CHF300000000 CHF

Historical Annual Operating Expenses of Tecan Group AG (2023 - 2002)

Year Operating Expenses Operating Expenses Growth
2023 254.49 Million CHF -1.88%
2022 259.36 Million CHF 5.05%
2021 246.89 Million CHF 13.85%
2020 216.86 Million CHF 11.89%
2019 193.8 Million CHF -0.24%
2018 194.26 Million CHF 4.83%
2017 185.32 Million CHF 6.58%
2016 173.88 Million CHF 16.38%
2015 149.41 Million CHF 0.68%
2014 148.4 Million CHF 10.71%
2013 134.04 Million CHF -8.17%
2012 145.96 Million CHF 3.92%
2011 140.45 Million CHF 7.89%
2010 130.18 Million CHF -6.56%
2009 139.32 Million CHF -12.85%
2008 159.85 Million CHF 4.28%
2007 153.29 Million CHF 6.8%
2006 143.52 Million CHF 5.41%
2005 136.16 Million CHF 10.54%
2004 123.17 Million CHF -9.7%
2003 136.41 Million CHF 0.27%
2002 136.04 Million CHF 0.0%

Peer Operating Expenses Comparison of Tecan Group AG

Name Operating Expenses Operating Expenses Difference
Relief Therapeutics Holding AG 114.94 Million CHF -121.417%
Santhera Pharmaceuticals Holding AG 31.33 Million CHF -712.188%
Basilea Pharmaceutica AG 111.63 Million CHF -127.974%
Bachem Holding AG 47.58 Million CHF -434.853%
Siegfried Holding AG 148.34 Million CHF -71.565%
Molecular Partners AG 20.3 Million CHF -1153.566%